Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

被引:322
|
作者
Reed, Caitlin [1 ]
Bryant, Richard [2 ,3 ]
Ibrahim, Ashraf S. [1 ,3 ]
Edwards, John, Jr. [1 ,3 ]
Filler, Scott G. [1 ,3 ]
Goldberg, Robert [2 ,3 ]
Spellberg, Brad [1 ,3 ]
机构
[1] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, Med Ctr, Dept Orbital & Ophthalm Plast Surg, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1086/589857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. It has been axiomatic that echinocandins ( e. g., caspofungin) are ineffective against mucormycosis. However, on the basis of preclinical data, we recently began treating rhino- orbital- cerebral mucormycosis ( ROCM) with combination polyene- caspofungin therapy. Methods. To determine the impact of polyene-caspofungin therapy, ROCM cases identified by an International Classification of Diseases, Ninth Revision search were retrospectively reviewed to gather data on demographic characteristics, clinical history, and outcomes. The predefined primary end point was success (i.e., the patients was alive and not in hospice care) at 30 days after hospital discharge. Results. Forty-one patients with biopsy-proven ROCM were identified over 12 years; 23 (56%) of these patients were Hispanic, and 34 (83%) were diabetic. Patients treated with polyene-caspofungin therapy (6 evaluable patients) had superior success (100% vs. 45%; P = .02) and Kaplan-Meier survival time (P = .02), compared with patients treated with polyene monotherapy. Patients treated with amphotericin B lipid complex had inferior success (37% vs. 72%; P= .03) and a higher clinical failure rate (45% vs. 21%; P = .04), compared with patients who received other polyenes. However, patients treated with amphotericin B lipid complex plus caspofungin had superior success (100% vs. 20%; P = .009) and survival time (P = .01), compared with patients who received amphotericin B lipid complex alone. The benefit of combination therapy, compared with monotherapy, was most pronounced in patients with cerebral involvement (success rate, 100% vs. 25%; P = .01). In multivariate analysis, only receipt of combination therapy was significantly associated with improved outcomes (odds ratio, 10.9; 95% confidence interval, 1.3-infinity; P = .02). Conclusions. Combination polyene-caspofungin therapy represents a promising potential alternative to polyene monotherapy for patients with ROCM. Randomized, prospective investigation of these findings is warranted.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 50 条
  • [31] Rhino-orbital-cerebral Mucormycosis in a known diabetic patient in Nigeria
    Oladele, R. O.
    Ettu, A.
    James, O.
    Adeyemo, W. B.
    Osigwe, U.
    Denning, D.
    MYCOSES, 2015, 58 : 163 - 163
  • [32] Rhino-orbital-cerebral mucormycosis with different cerebral involvements: infarct, hemorrhage, and ophthalmoplegia
    Koc, Zafer
    Filiz, Koc
    Yerdelen, Deniz
    Ozdogu, Hakan
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2007, 117 (12) : 1677 - 1690
  • [33] Unilateral rhino-orbital-cerebral mucormycosis with contralateral endogenous fungal endophthalmitis
    Ho, Hao Chi
    Liew, On Heong
    Teh, Swee Sew
    Hanizasurana, Hashim
    Ibrahim, Mohtar
    Shatriah, Ismail
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 553 - 556
  • [34] Rhino-orbital-cerebral mucormycosis in a diabetic ketoacidotic patient - case report
    Correia, F. C.
    Pereira, S.
    Toscano, C.
    Batista, J.
    Sabino, R.
    Verissimo, C.
    Lameiras, A. R.
    Donato, M.
    Escada, P. A.
    MYCOSES, 2017, 60 : 177 - 178
  • [35] Imaging Patterns of Rhino-Orbital-Cerebral Mucormycosis in Immunocompromised PatientsWhen to Suspect Complicated Mucormycosis
    Peter Raab
    Ludwig Sedlacek
    Stefanie Buchholz
    Stefan Stolle
    H. Lanfermann
    Clinical Neuroradiology, 2017, 27 : 469 - 475
  • [36] The Many Manifestations of Rhino-Orbital-Cerebral Mucormycosis: An Illustrative Case Report
    Trenz, Megan
    Tetreault, Lindsay
    NEUROLOGY, 2023, 100 (17)
  • [37] Rhino-Orbital-Cerebral Mucormycosis: A Lethal Complication of Body Dysmorphic Disorder
    Zaldivar, Renzo A.
    Leavitt, Jacqueline A.
    Griepentrog, Gregory J.
    Woog, John J.
    Bradley, Elizabeth A.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 25 (05): : 398 - 399
  • [38] Increased Incidence of Rhino-Orbital-Cerebral Mucormycosis After Colorado Flooding
    Davies, Brett W.
    Smith, Jesse M.
    Hink, Eric M.
    Durairaj, Vikram D.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (03): : S148 - S151
  • [39] Successful Treatment of a Case with Rhino-Orbital-Cerebral Mucormycosis by the Combination of Neurosurgical Intervention and the Sequential Use of Amphotericin B and Posaconazole
    Yoon, Young Kyung
    Kim, Min Ja
    Chung, Yong Gu
    Shin, Il Young
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2010, 47 (01) : 74 - 77
  • [40] Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report
    Alrefai, Ali H.
    Berger, Joseph R.
    Saadeh, Ruba S.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (02) : 144 - 147